[go: up one dir, main page]

ATA364384A - Verfahren zur herstellung neuer 6-vinyl-furo(3,4-c)-pyridinderivate - Google Patents

Verfahren zur herstellung neuer 6-vinyl-furo(3,4-c)-pyridinderivate

Info

Publication number
ATA364384A
ATA364384A AT0364384A AT364384A ATA364384A AT A364384 A ATA364384 A AT A364384A AT 0364384 A AT0364384 A AT 0364384A AT 364384 A AT364384 A AT 364384A AT A364384 A ATA364384 A AT A364384A
Authority
AT
Austria
Prior art keywords
furo
vinyl
pyridine derivatives
producing new
producing
Prior art date
Application number
AT0364384A
Other languages
English (en)
Other versions
AT391867B (de
Inventor
Andre Esanu
Original Assignee
Scras
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scras filed Critical Scras
Publication of ATA364384A publication Critical patent/ATA364384A/de
Application granted granted Critical
Publication of AT391867B publication Critical patent/AT391867B/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/06Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10Antioedematous agents; Diuretics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Hematology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
AT0364384A 1983-11-16 1984-11-16 Verfahren zur herstellung neuer 6-vinyl-furo(3,4-c)-pyridinderivate AT391867B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB838330517A GB8330517D0 (en) 1983-11-16 1983-11-16 6-vinyl-furo-(3,4-c)pyridine derivatives

Publications (2)

Publication Number Publication Date
ATA364384A true ATA364384A (de) 1990-06-15
AT391867B AT391867B (de) 1990-12-10

Family

ID=10551816

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0364384A AT391867B (de) 1983-11-16 1984-11-16 Verfahren zur herstellung neuer 6-vinyl-furo(3,4-c)-pyridinderivate

Country Status (25)

Country Link
US (1) US4569939A (de)
JP (1) JPS60112793A (de)
AT (1) AT391867B (de)
BE (1) BE900942A (de)
CA (1) CA1257271A (de)
CH (1) CH660738A5 (de)
DE (1) DE3442035A1 (de)
DK (1) DK157870C (de)
DZ (1) DZ701A1 (de)
ES (1) ES537665A0 (de)
FI (1) FI79852C (de)
FR (2) FR2554817B1 (de)
GB (2) GB8330517D0 (de)
HK (1) HK36087A (de)
IE (1) IE58005B1 (de)
IT (1) IT1213246B (de)
LU (1) LU85635A1 (de)
MA (1) MA20259A1 (de)
MY (1) MY101721A (de)
NL (1) NL8403353A (de)
OA (1) OA07864A (de)
PT (1) PT79511B (de)
SE (1) SE458116B (de)
SG (1) SG6687G (de)
ZA (1) ZA848130B (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8402740D0 (en) * 1984-02-02 1984-03-07 Scras Furo-(3 4-c)-pyridine derivatives
GB8422379D0 (en) * 1984-09-05 1984-10-10 Scras Derivatives
GB8808001D0 (en) * 1988-04-06 1988-05-05 Scras Stereospecific preparative process for furol(3,4-c)pyridine derivatives
GB8917168D0 (en) * 1989-07-27 1989-09-13 Scras Asymmetric synthesis of furo(3,4-c)pyridine derivatives
US5130252A (en) * 1990-05-14 1992-07-14 Synthetech, Inc. Resolution of furopyridine enantiomers and synthetic precursors thereof
EP0511163B1 (de) * 1991-04-24 1995-07-26 Ciba-Geigy Ag Fliessfähige wässrige Dispersionen von Polycarbonsäure-Korrosionsinhibitoren
EP1169322B8 (de) * 1999-03-08 2006-09-13 Medicure Inc. Pyridoxal-analoge zur behandlung von störungen ausgelöst durch einen vitamin b6 mangel
WO2001003682A2 (en) * 1999-07-13 2001-01-18 Medicure Inc. Use of pyridoxin derivatives for the treatment of diabetes and related complications
CA2383252A1 (en) * 1999-08-24 2001-03-01 Medicure International Inc. Treatment of cardiovascular related pathologies
DE60133323T2 (de) 2000-02-29 2009-03-05 Medicure International Inc. Cardioprotektive Phosphonate
US7442689B2 (en) * 2000-02-29 2008-10-28 Medicure International Inc. Cardioprotective phosphonates and malonates
AU784840B2 (en) 2000-03-28 2006-07-06 Medicure International Inc. Treatment of cerebrovascular disease
US6548519B1 (en) 2001-07-06 2003-04-15 Medicure International Inc. Pyridoxine and pyridoxal analogues: novel uses
ATE364595T1 (de) 2000-07-07 2007-07-15 Medicure Int Inc Pyridoxin- und pyridoxalanaloga als cardiovasculäre therapeutika
US6897228B2 (en) * 2000-07-07 2005-05-24 Medicure International Inc. Pyridoxine and pyridoxal analogues: new uses
US20040121988A1 (en) * 2001-03-28 2004-06-24 Medicure International Inc. Treatment of cerebrovascular disease
US20040186077A1 (en) * 2003-03-17 2004-09-23 Medicure International Inc. Novel heteroaryl phosphonates as cardioprotective agents
WO2006002549A1 (en) * 2004-07-07 2006-01-12 Medicure International Inc. Combination therapies employing platelet aggregation drugs
US20070060549A1 (en) * 2004-08-10 2007-03-15 Friesen Albert D Combination therapies employing ace inhibitors and uses thereof for the treatment of diabetic disorders
JP2008517956A (ja) * 2004-10-28 2008-05-29 メディキュア・インターナショナル・インコーポレーテッド 二重の抗血小板性/抗凝固性ピリドキシン類似体
US7459468B2 (en) * 2004-10-28 2008-12-02 Medicure International, Inc. Aryl sulfonic pyridoxines as antiplatelet agents
US20060094749A1 (en) * 2004-10-28 2006-05-04 Medicure International Inc. Substituted pyridoxines as anti-platelet agents
CA2632090A1 (en) * 2005-11-28 2007-05-31 Medicure International Inc. Selected dosage for the treatment of cardiovascular and related pathologies

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA786269B (en) * 1977-11-25 1979-10-31 Scras New pyridine derivative,its preparation and use
GB2008582B (en) * 1977-11-25 1982-04-28 Scras Pyridine derivative
IN156817B (de) * 1981-02-10 1985-11-09 Scras

Also Published As

Publication number Publication date
FR2554719B1 (fr) 1986-06-06
US4569939A (en) 1986-02-11
GB8330517D0 (en) 1983-12-21
PT79511B (en) 1986-09-08
GB2149782B (en) 1986-10-22
FI844279L (fi) 1985-05-17
PT79511A (en) 1984-12-01
GB2149782A (en) 1985-06-19
ES8600299A1 (es) 1985-09-16
GB8426490D0 (en) 1984-11-28
DK157870B (da) 1990-02-26
NL8403353A (nl) 1985-06-17
FI79852C (fi) 1990-03-12
DE3442035A1 (de) 1985-05-30
BE900942A (fr) 1985-02-15
MY101721A (en) 1992-01-17
DZ701A1 (fr) 2004-09-13
OA07864A (fr) 1986-11-20
SE8405710L (sv) 1985-05-17
IT8423565A0 (it) 1984-11-14
FR2554817A1 (fr) 1985-05-17
ZA848130B (en) 1985-06-26
HK36087A (en) 1987-05-08
JPH0314315B2 (de) 1991-02-26
CH660738A5 (fr) 1987-06-15
AT391867B (de) 1990-12-10
FR2554817B1 (fr) 1986-04-18
IE58005B1 (en) 1993-06-02
CA1257271A (en) 1989-07-11
IT1213246B (it) 1989-12-14
ES537665A0 (es) 1985-09-16
SE458116B (sv) 1989-02-27
FI844279A0 (fi) 1984-11-01
DK157870C (da) 1990-08-06
DK542584A (da) 1985-05-17
LU85635A1 (fr) 1985-06-04
SG6687G (en) 1987-06-05
FR2554719A1 (fr) 1985-05-17
MA20259A1 (fr) 1985-07-01
IE842930L (en) 1985-05-16
FI79852B (fi) 1989-11-30
SE8405710D0 (sv) 1984-11-14
JPS60112793A (ja) 1985-06-19
DK542584D0 (da) 1984-11-15

Similar Documents

Publication Publication Date Title
ATA71183A (de) Verfahren zur herstellung neuer 3-keto-delta 4,9,19-norsteroid-derivate
ATA364384A (de) Verfahren zur herstellung neuer 6-vinyl-furo(3,4-c)-pyridinderivate
AT373599B (de) Verfahren zur herstellung neuer rifamycinderivate
ATA27585A (de) Verfahren zur herstellung neuer 6-substituierter furo-(3,4-c)-pyridinderivate
AT389302B (de) Verfahren zur herstellung neuer 3-benzylidencamphersulfonamidderivate
ATA376184A (de) Verfahren zur herstellung neuer polysubstituierter naphthalinderivate
ATA365584A (de) Verfahren zur herstellung von 7-carboxymethoxyfuro-(3,4-c)-pyridinderivaten
ATA232384A (de) Verfahren zur herstellung neuer 1,5-benzothiazepine
ATA392384A (de) Verfahren zur herstellung neuer substituierter aminoguanidin-derivate
ATA165685A (de) Verfahren zur herstellung neuer 1,3-oxazolidin-2- derivate
AT379144B (de) Verfahren zur herstellung neuer 4,5-ungesaettigter 16-hydroxyprostansaeurederivate
ATA337185A (de) Verfahren zur herstellung neuer flavolignanderivate
ATA124285A (de) Verfahren zur herstellung neuer iminothiazolidinderivate
ATA332984A (de) Verfahren zur herstellung neuer 4-chloro substituierter furo-(3,4-c)-pyridinderivate
ATA310385A (de) Verfahren zur herstellung neuer 6-phenaethylaminoalkyl-7-hydroxy-furo-(3,4-c)pyridinderivate
ATA444982A (de) Verfahren zur herstellung neuer bisindolalkaloidderivate
ATA335685A (de) Verfahren zur herstellung neuer thienopyridinderivate
ATA305785A (de) Verfahren zur herstellung neuer 4h-dioxino-(4,5-c)-pyridinderivate
ATA371584A (de) Verfahren zur herstellung neuer cephalosporanderivate
AT376217B (de) Verfahren zur herstellung neuer 3-chlorchinolinderivate
ATA260285A (de) Verfahren zur herstellung neuer 6-aminomethyl-furo-(3,4-c)-pyridinderivate
AT375077B (de) Verfahren zur herstellung neuer 4-phenyl-4,5,6,7tetrahydropyrrolo(2,3-c)pyridine
AT387576B (de) Verfahren zur herstellung neuer 1,3-oxazino(4,3-a)isochinolin-derivate
ATA259384A (de) Verfahren zur herstellung neuer 2,4-dimethyl-2 -hexenderivate
AT383118B (de) Verfahren zur herstellung neuer azetidinonderivate

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee